Tianhua He

863 total citations
21 papers, 562 citations indexed

About

Tianhua He is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Tianhua He has authored 21 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 4 papers in Epidemiology and 3 papers in Infectious Diseases. Recurrent topics in Tianhua He's work include Hepatitis C virus research (9 papers), Liver Disease Diagnosis and Treatment (4 papers) and Peripheral Neuropathies and Disorders (3 papers). Tianhua He is often cited by papers focused on Hepatitis C virus research (9 papers), Liver Disease Diagnosis and Treatment (4 papers) and Peripheral Neuropathies and Disorders (3 papers). Tianhua He collaborates with scholars based in China, United States and Hong Kong. Tianhua He's co-authors include Jagpreet Chhatwal, María A. López-Olivo, Chin Hur, Turgay Ayer, Mark S. Roberts, John J. Grefenstette, Anne C. Spaulding, Kan Li, Zhou Fang and Wenzhao Xie and has published in prestigious journals such as Annals of Internal Medicine, Journal of Hepatology and Preventive Medicine.

In The Last Decade

Tianhua He

21 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tianhua He China 11 275 262 81 56 53 21 562
Xuezhang Duan China 12 301 1.1× 273 1.0× 82 1.0× 65 1.2× 24 0.5× 45 680
Hans Vandenberghe Belgium 11 93 0.3× 151 0.6× 48 0.6× 21 0.4× 33 0.6× 27 434
Devika Kapuria United States 9 146 0.5× 174 0.7× 15 0.2× 127 2.3× 27 0.5× 28 404
V. James United Kingdom 15 183 0.7× 188 0.7× 42 0.5× 19 0.3× 13 0.2× 31 592
Shaimaa Soliman Egypt 14 125 0.5× 144 0.5× 58 0.7× 101 1.8× 12 0.2× 59 556
Bandar Al Knawy Saudi Arabia 12 225 0.8× 236 0.9× 36 0.4× 44 0.8× 19 0.4× 14 432
Nicolas Scheuer Switzerland 8 101 0.4× 137 0.5× 19 0.2× 30 0.5× 27 0.5× 12 304
Naudia Jonassaint United States 10 131 0.5× 103 0.4× 27 0.3× 20 0.4× 10 0.2× 26 381
Nazir Ibrahim Syria 11 178 0.6× 213 0.8× 46 0.6× 25 0.4× 21 0.4× 29 470
Maryam Alavi Australia 22 971 3.5× 1.0k 3.8× 66 0.8× 155 2.8× 15 0.3× 65 1.2k

Countries citing papers authored by Tianhua He

Since Specialization
Citations

This map shows the geographic impact of Tianhua He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianhua He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianhua He more than expected).

Fields of papers citing papers by Tianhua He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianhua He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianhua He. The network helps show where Tianhua He may publish in the future.

Co-authorship network of co-authors of Tianhua He

This figure shows the co-authorship network connecting the top 25 collaborators of Tianhua He. A scholar is included among the top collaborators of Tianhua He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianhua He. Tianhua He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tong, Yongxin, Zimu Zhou, Yi Xu, et al.. (2025). Federated reasoning LLMs: a survey. Frontiers of Computer Science. 19(12). 1 indexed citations
2.
He, Tianhua, et al.. (2022). Pancreatic involvement in Erdheim-Chester disease: a case report and review of the literature. BMC Gastroenterology. 22(1). 302–302. 6 indexed citations
3.
He, Tianhua, et al.. (2021). [Efficacy and safety of vemurafenib in the treatment of BRAF(V600E)-mutated Erdheim-Chester disease].. PubMed. 42(9). 752–756. 1 indexed citations
4.
Feng, Jun, Xuemin Gao, Hao Zhao, et al.. (2020). Ischemic stroke in patients with POEMS syndrome. Blood Advances. 4(14). 3427–3434. 9 indexed citations
5.
He, Tianhua, Lijia Cui, Na Niu, et al.. (2020). Bone mineral density and bone microarchitecture in a cohort of patients with Erdheim-Chester Disease. Orphanet Journal of Rare Diseases. 15(1). 236–236. 6 indexed citations
6.
Cui, Lü, Tianhua He, Yan Jiang, et al.. (2019). Predicting the intervention threshold for initiating osteoporosis treatment among postmenopausal women in China: a cost-effectiveness analysis based on real-world data. Osteoporosis International. 31(2). 307–316. 15 indexed citations
7.
He, Tianhua, Zhuang Tian, Yongtai Liu, et al.. (2019). Evaluating heart function in patients with POEMS syndrome. Echocardiography. 36(11). 1997–2003. 4 indexed citations
8.
He, Tianhua, Ailin Zhao, Hao Zhao, et al.. (2019). Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy. Annals of Hematology. 98(3). 735–743. 11 indexed citations
9.
Chhatwal, Jagpreet, Sumeyye Samur, Tianhua He, et al.. (2018). Improved health outcomes from hepatitis C treatment scale-up in Spain’s prisons: A cost-effectiveness study. Journal of Hepatology. 68. S151–S151. 4 indexed citations
10.
Xie, Xiaolei, Tianhua He, Jian Kang, et al.. (2018). Cost-effectiveness analysis of intensive hypertension control in China. Preventive Medicine. 111. 110–114. 26 indexed citations
11.
Cao, Xinxin, Hao Cai, Tianhua He, et al.. (2017). Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease. Annals of Hematology. 96(6). 971–976. 22 indexed citations
12.
He, Tianhua, María A. López-Olivo, Chin Hur, & Jagpreet Chhatwal. (2017). Systematic review: cost‐effectiveness of direct‐acting antivirals for treatment of hepatitis C genotypes 2‐6. Alimentary Pharmacology & Therapeutics. 46(8). 711–721. 39 indexed citations
13.
Chhatwal, Jagpreet, Tianhua He, Chin Hur, & María A. López-Olivo. (2016). Direct-Acting Antiviral Agents for Patients With Hepatitis C Virus Genotype 1 Infection Are Cost-Saving. Clinical Gastroenterology and Hepatology. 15(6). 827–837.e8. 61 indexed citations
14.
Cui, Lijia, Weiming Zhao, Dongzhi Yang, et al.. (2016). Molecular epidemiology of hepatitis C infections in Ningxia, China: genotype, phylogeny and mutation analysis. Virology Journal. 13(1). 172–172. 8 indexed citations
15.
Chhatwal, Jagpreet, Tianhua He, & María A. López-Olivo. (2016). Systematic Review of Modelling Approaches for the Cost Effectiveness of Hepatitis C Treatment with Direct-Acting Antivirals. PharmacoEconomics. 34(6). 551–567. 60 indexed citations
16.
Chhatwal, Jagpreet & Tianhua He. (2015). Economic Evaluations with Agent-Based Modelling: An Introduction. PharmacoEconomics. 33(5). 423–433. 34 indexed citations
17.
He, Tianhua, Kan Li, Mark S. Roberts, et al.. (2015). Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons. Annals of Internal Medicine. 164(2). 84–92. 125 indexed citations
18.
Luo, Aijing, et al.. (2014). Doctor–patient communication skills training in mainland China: A systematic review of the literature. Patient Education and Counseling. 98(1). 3–14. 81 indexed citations
19.
He, Tianhua, Mark S. Roberts, John J. Grefenstette, & Jagpreet Chhatwal. (2014). Cost-effectiveness of hepatitis C screening in united states prisons: An agent-based approach. Value in Health. 17(3). A37–A37. 1 indexed citations
20.
Cui, Hong‐Kui, Jie Qing, Ye Guo, et al.. (2013). Stapled peptide-based membrane fusion inhibitors of hepatitis C virus. Bioorganic & Medicinal Chemistry. 21(12). 3547–3554. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuezhang Duan Breakdown of academic impact, for papers by Hans Vandenberghe Breakdown of academic impact, for papers by Devika Kapuria Breakdown of academic impact, for papers by V. James Breakdown of academic impact, for papers by Shaimaa Soliman Breakdown of academic impact, for papers by Bandar Al Knawy Breakdown of academic impact, for papers by Nicolas Scheuer Breakdown of academic impact, for papers by Naudia Jonassaint Breakdown of academic impact, for papers by Nazir Ibrahim Breakdown of academic impact, for papers by Maryam Alavi
Rankless by CCL
2026